Form 4 for EW Edwards Lifesciences
Accepted 2023-04-28 00:00:00 ET · period of report 2023-04-28 · accession 0001225208-23-005181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-28 | 2023-04-28 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | S - Sale+OE | $87.20 | -12.3K | 11.7K | -51% | -$1.07M |
| D | 2023-04-28 | 2023-04-28 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | M - OptEx | $35.20 | +12.3K | 24.0K | +104% | +$431.9K |
| D | 2023-04-28 | 2023-04-28 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | M - OptEx | $0.00 | -12.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | S | D | 12,270 | $87.20 | 11,749.79 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-28 | M | A | 12,270 | $35.20 | 24,019.79 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-04-28 | M | D | 12,270 | $0.00 | 0 | D | $35.20 · 2017-05-12 to 2023-05-11 | 12,270 Common Stock |